Z-D-Dbu(Fmoc)-OH is a protected amino acid derivative featuring a D-stereochemical center and an amino acid backbone bearing a benzyl-type Z (carbobenzyloxy) protecting group on the α-amino functionality, along with an Fmoc (9-fluorenylmethoxycarbonyl) protecting group also associated with the amino functionality as indicated by the name. The side chain is an alkyl substituent (Dbu) and the molecule contains a free carboxylic acid group (-COOH) that can participate in peptide coupling chemistry while the protected amino functionality is masked to control chemoselectivity. In peptide synthesis workflows, this orthogonally protected amino acid analogue is employed as a stepwise building block for constructing peptide chains and for preparing peptide-related intermediates where selective deprotection and subsequent coupling at the carboxyl group are required.
CAT No: CP25217
CAS No:1217471-94-7
Synonyms/Alias:(S)-4-(Fmoc-amino)-3-(Z-amino)butyric acid;Z-Dbu(Fmoc) (S)
Chemical Name:(S)-N-beta-Benzyloxycarbonyl-N-gamma-(9-fluorenylmethyloxycarbonyl)-3,4-diaminobutyric acid
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.